The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Pulmozyme 2500 U/ 2.5ml, nebuliser solution



Roche Products (Ireland) Ltd PA2307/005/001

Main Information

Trade NamePulmozyme 2500 U/ 2.5ml, nebuliser solution
Active SubstancesDornase alfa
Dosage FormNebuliser solution
Licence HolderRoche Products (Ireland) Ltd
Licence NumberPA2307/005/001

Group Information

ATC CodeR05CB Mucolytics
R05CB13 dornase alfa (desoxyribonuclease)

Status

License statusAuthorised
Licence Issued14/03/1994
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence 6.METHOD OF SALE OR SUPPLY Product subject to prescription which may be renewed (B) Supply through pharmacies only 7.METHOD OF SALES PROMOTION Promotion to healthcare professionals only
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back